Literature DB >> 2925048

Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews.

M P Roth1, G M Petersen, C McElree, C M Vadheim, J F Panish, J I Rotter.   

Abstract

Genetic factors have been implicated in the etiology of inflammatory bowel disease (IBD) because of the increased occurrence of IBD in relatives. To further characterize the familial aggregation of IBD, we obtained family histories by interview on 188 IBD patients, including 154 Ashkenazi Jews (82%), ascertained through a Los Angeles gastroenterology practice. Thirty-three index cases (17.6%) had at least one affected first-degree relative; an additional 11 had more distant affected relatives. Thus, 23.4% of our sample had a positive family history. The quantification of empiric risk estimates for various classes of relatives has been quite limited and has been reported in only a few series. An important goal of our study was the determination of the specific empiric risk figures for relatives. We obtained uncorrected risk estimates of 2.5% to off-spring, 5.2% to siblings, and 2.9% to parents. Although the highest risk we observed is to siblings, IBD has a variable and often late age of onset, and it is likely that many relatives, particularly offspring, of patients in this sample have not reached the age at which they will manifest clinical disease. Thus, these uncorrected risks as well as those reported in the literature are an underestimate of the true empiric risks. To provide an estimate of the true lifetime risks, we utilized age-specific incidence data to calculate the following age-corrected empiric risk estimates for IBD: 8.9% to offspring, 8.8% to siblings, and 3.5% to parents. It is these latter age-corrected estimates that are most appropriate for both genetic counseling and genetic modeling.

Entities:  

Mesh:

Year:  1989        PMID: 2925048     DOI: 10.1016/0016-5085(89)91618-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  43 in total

1.  Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease.

Authors:  J Hampe; N J Lynch; S Daniels; S Bridger; A J Macpherson; P Stokkers; A Forbes; J E Lennard-Jones; C G Mathew; M E Curran; S Schreiber
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

2.  Elevated basal intestinal mucosal cytokine levels in asymptomatic first-degree relatives of patients with Crohn's disease.

Authors:  Anant VK Indaram; Santa Nandi; Sam Weissman; Sing Lam; Beverly Bailey; Meyer Blumstein; Ronald Greenberg; Simmy Bank
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

3.  Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families.

Authors:  Turgut Tukel; Adel Shalata; Daniel Present; Daniel Rachmilewitz; Lloyd Mayer; Deniera Grant; Neil Risch; Robert J Desnick
Journal:  Am J Hum Genet       Date:  2004-03-05       Impact factor: 11.025

4.  Effects of family history on inflammatory bowel disease characteristics in Japanese patients.

Authors:  Erika Kuwahara; Keiko Asakura; Yuji Nishiwaki; Nagamu Inoue; Mamoru Watanabe; Toshifumi Hibi; Toru Takebayashi
Journal:  J Gastroenterol       Date:  2012-03-01       Impact factor: 7.527

5.  Familial aggregation of inflammatory bowel disease in a Mediterranean area.

Authors:  C Cipolla; A Magliocco; L Oliva; M Cottone
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

6.  Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis.

Authors:  U T Hacker; M Gomolka; E Keller; A Eigler; C Folwaczny; H Fricke; E Albert; K Loeschke; S Endres
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

7.  Genetic epistasis of IL23/IL17 pathway genes in Crohn's disease.

Authors:  Dermot P B McGovern; Jerome I Rotter; Ling Mei; Talin Haritunians; Carol Landers; Carrie Derkowski; Deb Dutridge; Marla Dubinsky; Andy Ippoliti; Eric Vasiliauskas; Emebet Mengesha; Lily King; Sheila Pressman; Stephan R Targan; Kent D Taylor
Journal:  Inflamm Bowel Dis       Date:  2009-06       Impact factor: 5.325

8.  Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea.

Authors:  Sook Hee Chung; Soo Jung Park; Hye Sun Lee; Sung Pil Hong; Jae Hee Cheon; Tae Il Kim; Won Ho Kim
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  IL18 polymorphism is associated with an increased risk of Crohn's disease.

Authors:  Kazuo Tamura; Yoshihiro Fukuda; Hiroko Sashio; Naohisa Takeda; Hiroko Bamba; Tadashi Kosaka; Shin Fukui; Koji Sawada; Kazutami Tamura; Masamichi Satomi; Takahiro Yamada; Takehira Yamamura; Yoshihiro Yamamoto; Jun-ichi Furuyama; Haruki Okamura; Takashi Shimoyama
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

10.  IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein.

Authors:  Kathrin S Michelsen; Lisa S Thomas; Kent D Taylor; Qi T Yu; Ling Mei; Carol J Landers; Carrie Derkowski; Dermot P B McGovern; Jerome I Rotter; Stephan R Targan
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.